73 related articles for article (PubMed ID: 35411033)
21. Functional redundancy of mitochondrial enoyl-CoA isomerases in the oxidation of unsaturated fatty acids.
van Weeghel M; te Brinke H; van Lenthe H; Kulik W; Minkler PE; Stoll MS; Sass JO; Janssen U; Stoffel W; Schwab KO; Wanders RJ; Hoppel CL; Houten SM
FASEB J; 2012 Oct; 26(10):4316-26. PubMed ID: 22782973
[TBL] [Abstract][Full Text] [Related]
22. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
23. KLF5 and NFYA factors as novel regulators of prostate cancer cell metabolism.
Poluri RTK; Paquette V; Allain ÉP; Lafront C; Joly-Beauparlant C; Weidmann C; Droit A; Guillemette C; Pelletier M; Audet-Walsh É
Endocr Relat Cancer; 2021 Apr; 28(4):257-271. PubMed ID: 33690159
[TBL] [Abstract][Full Text] [Related]
24. RNA sequencing data of human prostate cancer cells treated with androgens.
Poluri RTK; Beauparlant CJ; Droit A; Audet-Walsh É
Data Brief; 2019 Aug; 25():104372. PubMed ID: 31485472
[TBL] [Abstract][Full Text] [Related]
25. Respiratory Capacity and Reserve Predict Cell Sensitivity to Mitochondria Inhibitors: Mechanism-Based Markers to Identify Metformin-Responsive Cancers.
Teh JT; Zhu WL; Newgard CB; Casey PJ; Wang M
Mol Cancer Ther; 2019 Mar; 18(3):693-705. PubMed ID: 30824582
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.
Zadra G; Ribeiro CF; Chetta P; Ho Y; Cacciatore S; Gao X; Syamala S; Bango C; Photopoulos C; Huang Y; Tyekucheva S; Bastos DC; Tchaicha J; Lawney B; Uo T; D'Anello L; Csibi A; Kalekar R; Larimer B; Ellis L; Butler LM; Morrissey C; McGovern K; Palombella VJ; Kutok JL; Mahmood U; Bosari S; Adams J; Peluso S; Dehm SM; Plymate SR; Loda M
Proc Natl Acad Sci U S A; 2019 Jan; 116(2):631-640. PubMed ID: 30578319
[TBL] [Abstract][Full Text] [Related]
27. The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy.
Bramhecha YM; Rouzbeh S; Guérard KP; Scarlata E; Brimo F; Chevalier S; Hamel L; Aprikian AG; Lapointe J
Mod Pathol; 2019 Jan; 32(1):128-138. PubMed ID: 30140035
[TBL] [Abstract][Full Text] [Related]
28. Krüppel-like factor 4 (KLF4) induces mitochondrial fusion and increases spare respiratory capacity of human glioblastoma cells.
Wang S; Shi X; Wei S; Ma D; Oyinlade O; Lv SQ; Ying M; Zhang YA; Claypool SM; Watkins P; Xia S
J Biol Chem; 2018 Apr; 293(17):6544-6555. PubMed ID: 29507094
[TBL] [Abstract][Full Text] [Related]
29. Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome after Surgical Intervention.
Bramhecha YM; Guérard KP; Rouzbeh S; Scarlata E; Brimo F; Chevalier S; Hamel L; Dragomir A; Aprikian AG; Lapointe J
Mol Cancer Res; 2018 Jan; 16(1):115-123. PubMed ID: 28993510
[TBL] [Abstract][Full Text] [Related]
30. Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade.
Flaig TW; Salzmann-Sullivan M; Su LJ; Zhang Z; Joshi M; Gijón MA; Kim J; Arcaroli JJ; Van Bokhoven A; Lucia MS; La Rosa FG; Schlaepfer IR
Oncotarget; 2017 Aug; 8(34):56051-56065. PubMed ID: 28915573
[TBL] [Abstract][Full Text] [Related]
31. Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer.
Audet-Walsh É; Dufour CR; Yee T; Zouanat FZ; Yan M; Kalloghlian G; Vernier M; Caron M; Bourque G; Scarlata E; Hamel L; Brimo F; Aprikian AG; Lapointe J; Chevalier S; Giguère V
Genes Dev; 2017 Jun; 31(12):1228-1242. PubMed ID: 28724614
[TBL] [Abstract][Full Text] [Related]
32. Lipid degradation promotes prostate cancer cell survival.
Itkonen HM; Brown M; Urbanucci A; Tredwell G; Ho Lau C; Barfeld S; Hart C; Guldvik IJ; Takhar M; Heemers HV; Erho N; Bloch K; Davicioni E; Derua R; Waelkens E; Mohler JL; Clarke N; Swinnen JV; Keun HC; Rekvig OP; Mills IG
Oncotarget; 2017 Jun; 8(24):38264-38275. PubMed ID: 28415728
[TBL] [Abstract][Full Text] [Related]
33. The role of fatty acid β-oxidation in lymphangiogenesis.
Wong BW; Wang X; Zecchin A; Thienpont B; Cornelissen I; Kalucka J; García-Caballero M; Missiaen R; Huang H; Brüning U; Blacher S; Vinckier S; Goveia J; Knobloch M; Zhao H; Dierkes C; Shi C; Hägerling R; Moral-Dardé V; Wyns S; Lippens M; Jessberger S; Fendt SM; Luttun A; Noel A; Kiefer F; Ghesquière B; Moons L; Schoonjans L; Dewerchin M; Eelen G; Lambrechts D; Carmeliet P
Nature; 2017 Feb; 542(7639):49-54. PubMed ID: 28024299
[TBL] [Abstract][Full Text] [Related]
34. Androgen-Dependent Repression of ERRγ Reprograms Metabolism in Prostate Cancer.
Audet-Walsh É; Yee T; McGuirk S; Vernier M; Ouellet C; St-Pierre J; Giguère V
Cancer Res; 2017 Jan; 77(2):378-389. PubMed ID: 27821488
[TBL] [Abstract][Full Text] [Related]
35. Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation.
McDonnell E; Crown SB; Fox DB; Kitir B; Ilkayeva OR; Olsen CA; Grimsrud PA; Hirschey MD
Cell Rep; 2016 Nov; 17(6):1463-1472. PubMed ID: 27806287
[TBL] [Abstract][Full Text] [Related]
36. Proteogenomics connects somatic mutations to signalling in breast cancer.
Mertins P; Mani DR; Ruggles KV; Gillette MA; Clauser KR; Wang P; Wang X; Qiao JW; Cao S; Petralia F; Kawaler E; Mundt F; Krug K; Tu Z; Lei JT; Gatza ML; Wilkerson M; Perou CM; Yellapantula V; Huang KL; Lin C; McLellan MD; Yan P; Davies SR; Townsend RR; Skates SJ; Wang J; Zhang B; Kinsinger CR; Mesri M; Rodriguez H; Ding L; Paulovich AG; Fenyö D; Ellis MJ; Carr SA;
Nature; 2016 Jun; 534(7605):55-62. PubMed ID: 27251275
[TBL] [Abstract][Full Text] [Related]
37. Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer.
Park JH; Vithayathil S; Kumar S; Sung PL; Dobrolecki LE; Putluri V; Bhat VB; Bhowmik SK; Gupta V; Arora K; Wu D; Tsouko E; Zhang Y; Maity S; Donti TR; Graham BH; Frigo DE; Coarfa C; Yotnda P; Putluri N; Sreekumar A; Lewis MT; Creighton CJ; Wong LC; Kaipparettu BA
Cell Rep; 2016 Mar; 14(9):2154-2165. PubMed ID: 26923594
[TBL] [Abstract][Full Text] [Related]
38. Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate.
Dueregger A; Schöpf B; Eder T; Höfer J; Gnaiger E; Aufinger A; Kenner L; Perktold B; Ramoner R; Klocker H; Eder IE
PLoS One; 2015; 10(8):e0135704. PubMed ID: 26285134
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial complex II is a source of the reserve respiratory capacity that is regulated by metabolic sensors and promotes cell survival.
Pfleger J; He M; Abdellatif M
Cell Death Dis; 2015 Jul; 6(7):e1835. PubMed ID: 26225774
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
